These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35579151)

  • 21. Recent advances in the chemistry and biology of pyridopyrimidines.
    Buron F; Mérour JY; Akssira M; Guillaumet G; Routier S
    Eur J Med Chem; 2015 May; 95():76-95. PubMed ID: 25794791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature.
    Kaur R; Kaur P; Sharma S; Singh G; Mehndiratta S; Bedi PM; Nepali K
    Recent Pat Anticancer Drug Discov; 2015; 10(1):23-71. PubMed ID: 25230072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrimidine-fused Derivatives: Synthetic Strategies and Medicinal Attributes.
    Joshi G; Nayyar H; Alex JM; Vishwakarma GS; Mittal S; Kumar R
    Curr Top Med Chem; 2016; 16(28):3175-3210. PubMed ID: 27150371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterocyclic pyrimidine derivatives as promising antibacterial agents.
    Ahmed K; Choudhary MI; Saleem RSZ
    Eur J Med Chem; 2023 Nov; 259():115701. PubMed ID: 37591149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
    Abdallah AEM; Elgemeie GH
    Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Overview on Synthetic and Medicinal Perspectives of [1,2,4]Triazolo[1,5-a]pyrimidine Scaffold.
    Merugu SR; Cherukupalli S; Karpoormath R
    Chem Biodivers; 2022 Sep; 19(9):e202200291. PubMed ID: 35946991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and analgesic/anti-inflammatory evaluation of fused heterocyclic ring systems incorporating phenylsulfonyl moiety.
    Shaaban MR; Saleh TS; Mayhoub AS; Mansour A; Farag AM
    Bioorg Med Chem; 2008 Jun; 16(12):6344-52. PubMed ID: 18502132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
    Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
    Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverse Synthetic Approaches and Biological Activities of Lucrative Pyrimidine- Triazine Hybrid Derivatives: A Review.
    Asgaonkar K; Patil S; Pradhan K; Tanksali S; Jain J
    Curr Org Synth; 2023; 20(7):734-757. PubMed ID: 36125826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates.
    Islam F; Quadery TM
    Curr Drug Targets; 2021; 22(17):1944-1963. PubMed ID: 34042033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the Biological Activities of Pyrimido[4,5-d]pyrimidines.
    Cruz JS; de Aguiar AP
    Mini Rev Med Chem; 2021; 21(15):2138-2168. PubMed ID: 33605856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold.
    Yadav P; Shah K
    Chem Biol Drug Des; 2021 Mar; 97(3):633-648. PubMed ID: 32946161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives.
    Sondhi SM; Singh N; Johar M; Kumar A
    Bioorg Med Chem; 2005 Nov; 13(22):6158-66. PubMed ID: 16115773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update.
    Dorababu A
    Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200154. PubMed ID: 35698212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening.
    Bruno O; Schenone S; Ranise A; Bondavalli F; Barocelli E; Ballabeni V; Chiavarini M; Bertoni S; Tognolini M; Impicciatore M
    Bioorg Med Chem; 2001 Mar; 9(3):629-36. PubMed ID: 11310597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review.
    Manna T; Maji S; Maity M; Debnath B; Panda S; Khan SA; Nath R; Akhtar MJ
    Mol Divers; 2024 Jun; ():. PubMed ID: 38856835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,3,4-Thiadiazolo (3,2-Α) Pyrimidine-6-Carbonitrile Scaffold as PARP1 Inhibitors.
    Kaviarasan L; Eldhose E; Krishnamurthy PT; Rajagopal K; Mohammed M; Prudviraj P; Byran G
    Anticancer Agents Med Chem; 2021; 21(15):2050-2065. PubMed ID: 33327923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of benzo[b]thiophene-based medicinal chemistry.
    Keri RS; Chand K; Budagumpi S; Balappa Somappa S; Patil SA; Nagaraja BM
    Eur J Med Chem; 2017 Sep; 138():1002-1033. PubMed ID: 28759875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
    Tian Y; Du D; Rai D; Wang L; Liu H; Zhan P; De Clercq E; Pannecouque C; Liu X
    Bioorg Med Chem; 2014 Apr; 22(7):2052-9. PubMed ID: 24631361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.
    Pathania S; Rawal RK
    Eur J Med Chem; 2018 Sep; 157():503-526. PubMed ID: 30114661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.